fashion -WSS

fashion

author：explore 2025-09-27 23:52:06 - browse：9

Adam's take main illustration — Molly Ferguson/STAT

The eye disease physician in charge of a committee that flagged a rare but severe side effect involving a newly approved drug from Apellis Pharmaceuticals has financial ties to a competing drugmaker. The conflict raises questions about his supervision of an emerging safety issue for patients and its impact on the financial health of Apellis.

Peter Kaiser, a retinal disease expert who runs the Cole Eye Institute at the Cleveland Clinic, failed to report consulting fees and stock ownership in Iveric Bio on a financial disclosure form maintained by the American Society of Retina Specialists, or ASRS. Iveric Bio is developing a treatment for geographic atrophy, a common, age-related cause of vision loss and the same indication for which the Apellis drug was approved.

The financial conflict, which was undisclosed until after Kaiser was contacted about it by STAT, is relevant because Kaiser also chairs a committee of the ASRS responsible for monitoring the safety of retina drugs and devices. On July 15, Kaiser’s committee sent a letter to member doctors, alerting them to reports of eye inflammation in people receiving injections of Syfovre, the treatment recently approved and launched by Apellis.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： Guidelines to prevent youth baseball injuries need more muscle
Next article： Wegovy cuts risk of cardiovascular events by 20%, study finds

WSS

Chamber of Commerce, DOJ clash in court over drug prices

Astronauts get first look at the spacecraft that will fly them around the moon

Former Georgia lieutenant governor says he received grand jury subpoena

Grad students accuse University of California of wage theft

In venture capital firm's success, lessons for turning crisis into profit

People with substance use disorder deserve online privacy

hotspot

fashion

hotspot

Activists slam private health insurers over coverage restrictions

People with substance use disorder deserve online privacy

Indiana Supreme Court upholds abortion ban, says state constitution gives only limited protections

'A game

Medicare proposal to cover medical devices draws a mixed reaction

Akili changes sales model for its ADHD video game treatment

After affirmative action ruling, medical educators look to 'holistic review'

Free Covid tests will again be offered to all U.S. households

Hepatitis C has a cure — but many Americans still lack access to it

Grad students accuse University of California of wage theft

hotspot

The unintended consequences of overturning Roe v. Wade

David Liu startup to focus on CRISPR delivery

In venture capital firm's success, lessons for turning crisis into profit

More regulation could be coming for drug ads

Grad students accuse University of California of wage theft

The painfully weak evidence on taking collagen to treat arthritis

knowledge

leisure time

focus

focus